Hypersensitivity: Clinical Trials

893 trials for Hypersensitivity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

625 completed, 93 unknown, 63 terminated, 39 recruiting. 893 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 4893Completed 625, Unknown 93, Terminated 63, Recruiting 39, Withdrawn 26, Not yet recruiting 23, Active not recruiting 22, Enrolling by invitation 2

Follow Hypersensitivity: new trials by email Literature Review of Hypersensitivity trials Research Report on Hypersensitivity

Trials (filtered) newest first · largest first

All 893 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patients
Skin Cleanser Combination No.1 - Atopic Dermatitis
Phase 4Not yet recruitingBoston Children's Hospital1002031-01-012026-03-10
Prevent Wheeze Trial
Dexamethasone 0.6 mg/kilogram body weight single dose, Placebo - Lower Respiratory Tract Infection (LRTI), Recurrent Wheezing
Phase 4Not yet recruitingNorwegian University of Science and Technology4862027-02-012026-10-05
Opzelura Experience Study
ruxolitinib, ruxolitinib and an Eczema Action Plan - Atopic Dermatitis
Phase 4Not yet recruitingWake Forest University Health Sciences502026-12-012026-09-04
AD Treatment Optimization With Ebglyss in Real-World Practice: A Multicenter Study of Patient-Centered Outcomes
Lebrikizumab-lbkz - Atopic Dermatitis
Phase 4Not yet recruitingForefront Dermatology S.C2502026-11-112026-10-02
Novel Method for Removal of Orally Deposited Inhaled Fluticasone Propionate
Fluticasone Propionate, Water Mouthwash, EVOOW Mouthwash - Asthma
Phase 4Not yet recruitingUniversity of Wisconsin, Madison202026-11-012026-11-05
A Study to Investigate Dupixent/ Dupilumab in Adult Indian Participants With Moderate-to-severe Atopic Dermatitis
Dupilumab - Atopic Dermatitis
Phase 4Not yet recruitingSanofi562026-10-282026-10-29
Oral Food Challenge After One to Two Doses of Omalizumab Treatment for Food Allergy
Omalizumab - Food Allergy
Phase 4RecruitingJohns Hopkins University202026-10-192026-10-28
Gabapentin vs. Benzonatate vs. Standard of Care for Cough in ILD
Gabapentin, Benzonatate 200 mg, Standard of care treatment for ILD - Interstitial Lung Disease
Phase 4Not yet recruitingPost Graduate Institute of Medical Education and Research, Chandigarh1772026-10-072026-10-08
Abrocitinib Dose Tapering in Patients With Atopic Dermatitis
Abrocitinib - Atopic Dermatitis
Phase 4Not yet recruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS1002026-10-012026-09-29
A Study to Visualize Multi-Symptom Allergy in Adults With Seasonal Allergic Rhinitis
Fluticasone propionate - Rhinitis Allergic, Rhinitis Seasonal
Phase 4Not yet recruitingHALEON162026-09-012026-09-14
Reliability of Expired Allergens in Patch Testing: A Comparative Study With Non-Expired Series
Patch 1 (Expired), Patch 2 (non-expired) - Allergic Contact Dermatitis
Phase 4Not yet recruitingUniversity of Calgary1002026-09-012026-08-14
Comparison of Antihistamine and Antileukotriene Add-On Therapy to Intranasal Corticosteroid in Allergic Rhinitis
Mometasone Furoate Nasal spray, Loratadine 10 Mg, Montelukast 10 mg - Allergic Rhinitis (AR)
Phase 4Not yet recruitingLiaquat National Hospital & Medical College322026-09-012026-04-16
Safety and Effectiveness of Sebetralstat (KVD900) for Short-Term Prophylaxis Before Procedures in People With Hereditary Angioedema (KONTROL)
KVD900 600 mg - Hereditary Angioedema
Phase 4RecruitingKalVista Pharmaceuticals, Ltd.1002026-08-172026-09-17
The Impact of Dietary Salt on the Severity of Eczema
Sodium chloride tablets, Placebo Tablets - Eczema, Atopic Dermatitis
Phase 4RecruitingUniversity of California, San Francisco402026-08-102026-09-10
Azithromycin in Atopic Dermatitis
Betamethasone or tacrolimus ointments, Azithromycin - Atopic Dermatitis
Phase 4Not yet recruitingCairo University402026-08-012026-07-20
Utilization of a Microdevice for Psoriasis and Atopic Dermatitis
In situ cutaneous microdevice, Triamcinolone, 5-Fluorouracil - Psoriasis, Atopic Dermatitis
Phase 4Not yet recruitingUniversity of California, San Francisco102026-08-012026-06-03
Evaluation of ALLERgen Specific Vaccination of DOG Allergic Patients in Swedish Practice
ALK Alutard SQ Dog - Allergic Rhinitis, Asthma (Diagnosis)
Phase 4RecruitingKarolinska Institutet402026-08-012026-06-29
Giving Asthmatics Intramuscular Steroids for Preventing Return to the Emergency Department
Dexamethasone 16mg IM, Prednisone 60mg PO - Asthma
Phase 4RecruitingMontefiore Medical Center1822026-07-232026-07-24
Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream.
Roflumilast Cream 0.15% - ITCH, Atopic Dermatitis
Phase 4RecruitingIntegrative Skin Science and Research402026-07-212026-08-13
The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease
Sodium chloride tablets, Placebo Tablets - Atopic Dermatitis (Eczema), Psoriasis
Phase 4RecruitingUniversity of California, San Francisco502026-07-142026-09-09

Showing 20 of 893. Sign in to see all of them.

Narrower conditions

Asthma (430)  ·  Dermatitis, Atopic (136)  ·  Rhinitis, Allergic (96)  ·  Rhinitis, Allergic, Seasonal (53)  ·  Conjunctivitis, Allergic (40)  ·  Rhinitis, Allergic, Perennial (34)  ·  Eczema (27)  ·  Pulmonary Disease, Chronic Obstructive (25)  ·  Sarcoidosis (18)  ·  Urticaria (16)  ·  Pulmonary Eosinophilia (15)  ·  Rhinitis (15)  ·  Chronic Urticaria (14)  ·  Eosinophilic Esophagitis (11)

Broader conditions

Immune System Diseases (890)  ·  Hypersensitivity, Immediate (831)  ·  Respiratory Tract Diseases (611)  ·  Respiratory Hypersensitivity (585)  ·  Lung Diseases (449)  ·  Bronchial Diseases (441)  ·  Lung Diseases, Obstructive (434)  ·  Skin and Connective Tissue Diseases (190)  ·  Skin Diseases (189)  ·  Otorhinolaryngologic Diseases (178)  ·  Nose Diseases (175)  ·  Rhinitis (155)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (148)  ·  Genetic Diseases, Inborn (147)

Interventions

Fluticasone (74)  ·  montelukast (57)  ·  Albuterol (48)  ·  Budesonide (46)  ·  dupilumab (43)  ·  Omalizumab (42)  ·  Fluticasone-Salmeterol Drug Combination (34)  ·  desloratadine (26)  ·  Mometasone Furoate (25)  ·  levocetirizine (24)  ·  Salmeterol Xinafoate (22)  ·  pimecrolimus (21)  ·  Olopatadine Hydrochloride (19)  ·  fexofenadine (18)  ·  Cetirizine (17)

Sponsors

GlaxoSmithKline (67)  ·  Organon and Co (46)  ·  AstraZeneca (25)  ·  Sanofi (23)  ·  Novartis (16)  ·  University of Dundee (15)  ·  Alcon Research (14)  ·  University of California, San Francisco (14)  ·  Medical University of Lodz (12)  ·  University of Chicago (12)  ·  University of Saskatchewan (12)  ·  Novartis Pharmaceuticals (10)  ·  Imperial College London (9)  ·  Centre of Chinese Medicine, Georgia (8)  ·  Astellas Pharma Inc (7)

Countries

United States (341)  ·  Canada (85)  ·  United Kingdom (70)  ·  Germany (52)  ·  Italy (44)  ·  China (35)  ·  France (33)  ·  Spain (32)  ·  Netherlands (30)  ·  Poland (30)  ·  Denmark (28)  ·  Belgium (27)  ·  Australia (19)  ·  Sweden (19)  ·  Brazil (17)

Top investigators

Don Cockcroft, MD (6)  ·  Iwona Stelmach, MD, PhD, Prof (6)  ·  Manana Tchaia, MD (6)  ·  Merab Lomia, MD, PhD (6)  ·  Phyllis Diener (6)  ·  Robert P Baughman, MD (6)  ·  Brian Lipworth, MD (5)  ·  Robert M Naclerio, MD (5)

Results publications

PMID 18331513, PMID 20167147, PMID 20642206, PMID 25260889, PMID 32298853, PMID 33369570, PMID 36472162, PMID 37347518, PMID 37536444, PMID 37952772, PMID 10049409, PMID 10109801, PMID 11113831, PMID 11558866, PMID 11825832, PMID 12045120, PMID 12612294, PMID 15225842, PMID 15823451, PMID 15922813, PMID 16140398, PMID 16226443, PMID 16278257, PMID 16329022, PMID 16478839, PMID 16597501, PMID 16680006, PMID 16687712, PMID 16846553, PMID 16913264, PMID 17046300, PMID 17075269, PMID 17507702, PMID 17585003, PMID 17610727, PMID 17629923, PMID 17766511, PMID 17919504, PMID 18256392, PMID 18263672, PMID 18385500, PMID 18399898, PMID 18430310, PMID 18583517, PMID 18951618, PMID 18990678, PMID 19127072, PMID 19133920, PMID 19134016, PMID 19164187

NIH funding

2015 (6), 2019 (6), 2017 (5), 2018 (5), 2014 (4), 2004 (3), 2023 (3), 2005 (2), 2016 (2), 2025 (2), 2008 (1), 2009 (1), K23HL171940 (1), P01HL128191 (1), P50HL056385 (1)